Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-responsive element-binding protein 1 (RREB1) is an evolutionarily conserved zinc finger transcription factor that acts downstream of the RAS signaling pathway, binding RAS-responsive elements in gene promoters and influencing gene expression through both repression and activation. RREB1 integrates multiple signaling pathways (e.g., EGFR/MAPK, JAK/STAT, TGF-β/SMAD, Notch, Sonic Hedgehog) and is involved in numerous cellular processes, including regulation of cell adhesion, epithelial architecture, cytoskeletal dynamics, proteostasis, and embryonic development. Mutations or dysregulation of RREB1 contribute to cancer progression and metastasis by promoting epithelial-to-mesenchymal transition, and to developmental syndromes such as Noonan-like RASopathies. In neurons, RREB1 is critical for maintaining the microtubule network and proteostasis, and its deficiency leads to degeneration of Purkinje cells and ataxia, highlighting its role in neurodegenerative disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-responsive element-binding protein 1 (RREB1).